Skip to main content

Insurance for All by 2047: A Promise Now Carries a Deadline

In 2022, in an essay on this blog imagining India @ 100, I let myself picture 2047 and did not much like what I saw. The country was larger and richer, yet also older and less healthy, weighed down by a rising burden of non-communicable disease and a protection gap that refused to close. I wrote then that insurance penetration had improved but still trailed its peers. I also noted that the regulator, taking a leaf from the Reserve Bank of India's book, had begun opening the sector to mutuals and cooperatives to reach those the market had overlooked. It was a thought experiment. What has changed since is that 2047 is no longer only my imagined horizon. It has become an official one.

The Insurance Regulatory and Development Authority of India (IRDAI) has made an official mission of “Insurance for All by 2047”, placing it within the government's broader Viksit Bharat plan. The aim is for every citizen to have appropriate life, health, and property cover, for every enterprise to be suitably insured, and for the sector itself to become globally attractive. To move from slogan to system, the regulator has allotted states and union territories to individual insurers. It has also begun assembling what it calls the Bima Trinity: Bima Sugam, a digital marketplace; Bima Vistaar, an affordable, bundled product; and Bima Vahak, a village-level distribution force. In September 2025, the government cut the eighteen per cent GST on individual life and health premiums to nil, a genuine and long-overdue nudge on affordability. And in December 2025, Parliament passed the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Act, allowing up to 100 per cent foreign direct investment in insurance companies, opening the doors for capital and technology. 

The difficulty is that the baseline from which all this must climb has been moving in the wrong direction. According to IRDAI's annual report for 2024-25, overall insurance penetration remained stuck at 3.7 per cent of Gross Domestic Product (GDP), with life at 2.7 per cent and non-life at 1 per cent. It had peaked at 4.2 per cent during the Covid-19 pandemic in 2021-22 and has slipped every year since, with life insurance now in its third straight year of decline. The global average in 2024 was 7.3 per cent, so the distance is considerable. The often-cited aspiration of doubling penetration to eight per cent, therefore, asks the sector to reverse a trend before it can accelerate. Density tells the same story: USD 97 of premium per person against a world average of USD 943. Most telling, however, is that the life insurers issued 7.39 per cent fewer new individual policies during the year, even as premiums rose. The industry appears to be selling larger policies to those already inside the tent rather than bringing new households in.

For a blog concerned with how Indians pay for their health, the more consequential numbers sit in the National Health Accounts (NHA). The progress of the past decade was real. The share of out-of-pocket expenditure (OOPE) in total health spending fell from 62.6 per cent in 2014-15 to 39.4 per cent in 2021-22. Over the same span, the government's share rose from 29 to 48 per cent, and per capita government health spending nearly tripled. The composition also shifted, and the insurance-shaped portion grew fastest. Social security expenditure on health, which includes government-funded insurance and reimbursements, rose from about six per cent of the total to nearly 10 per cent, while the private health insurance share climbed from 3.4 to 9.2 per cent. India is already financing more of its health through pooled and pre-paid mechanisms rather than cash at the counter, which is precisely the transition the 2047 vision assumes.

Yet the most recent accounts, for 2022-23, temper the optimism: much of the earlier gain rested on emergency pandemic outlays that have since receded. OOPE edged back up to a little over 43 per cent, the government's share eased to about 44 per cent, and government health expenditure settled near 1.4 to 1.5 per cent of GDP. That is well short of the 2.5 per cent the National Health Policy of 2017 promised for 2025, a target now quietly missed. Two structural facts sit behind the shortfall. Health is largely a state subject, and about two-thirds of government health spending has historically been borne by the states rather than the union, so a centrally framed vision leans on fiscal capacity the centre does not fully control. The deeper ceiling is one I have written about before on this blog: a modest tax-to-GDP ratio leaves the exchequer little room to fund assurance at the scale universal coverage demands. In my centenary essay, I guessed that public health spending would breach two per cent only around 2030, and nothing in the current data convinces me to revise that upward. A promise of cover for all, resting on such a thin public base, is under strain from the outset.

Where the assurance leg has done real work is at the two ends of the age pyramid. As I noted in a recent post, the Ayushman Bharat scheme had by mid-2026 generated over 447 million cards and authorised nearly 127 million hospital admissions worth about 1,920 billion rupees, at an average of roughly Rs. 15,000 per admission. The extension of cover to every citizen aged seventy and above, through the Ayushman Vay Vandana card and without any income test, added close to ten million enrolments by the end of 2025. This is meaningful protection for the poorest half and the oldest cohort and deserves acknowledgement.

The unsolved problem lies where it always did, in the middle. The diagnosis by the National Institution for Transforming India (NITI) Aayog remains the sharpest framing of it. At least 30 per cent of the population, around 400 million people it called the missing middle, carry no financial protection for health at all. This is not a tidy income band. It spans every expenditure quintile and both town and country, from the informal self-employed to many semi-formal and formal urban workers. They sit between the tax-funded schemes below them and the private policies above, and they cannot simply be folded into the former. The subsidised and contributory products that already exist, whether Ayushman Bharat or the Employees' State Insurance Scheme (ESIC), are closed products. They are restricted to defined beneficiaries, precisely to guard against the adverse selection that opening them up would invite. The arithmetic of exclusion is unforgiving. A senior member of the same body noted in late 2025 that families spending Rs. 16,000 to Rs. 17,000 a month on essentials face annual premiums of Rs. 24,000 to Rs. 66,000 for cover comparable to Ayushman Bharat.

This is where feasibility is truly decided, and where I find the vision least convincing. NITI's own prescription leans on voluntary, contributory insurance sold mainly by private commercial insurers, an approach that has been fairly criticised for seeking universal coverage with few or no fiscal implications for the government. A voluntary pool aimed at a price-sensitive group invites the healthy to stay out and the unwell to buy in, and each round of that logic pushes premiums higher and coverage thinner. The friction policyholders already report does little for trust: health remains the fastest-growing segment, yet insurers processed some 32.6 million claims in the year and repudiated roughly 8.3 per cent of them. Some promising bridges are being built, including a plan to extend Ayushman Bharat to gig workers earning between Rs. 15,000 and Rs. 25,000 a month, and Bima Vistaar is built for exactly this segment. Both are promising, but neither is proven at the scale the target requires.

So, the honest assessment is mixed. The direction of policy is sound, and the instruments are, for the first time, reasonably coherent. Against that stand stubborn facts. Penetration is falling, not rising. The regulator has itself flagged mis-selling, and grievances rose by roughly 20 per cent, a trust deficit that corrodes any project built on voluntary uptake. Full foreign ownership brings capital, but capital has rarely been the binding constraint in reaching the informal sector, and without a matching answer on affordability, it may only sharpen competition for the well-insured few. Beneath it all runs the demographic clock I wrote about in 2022, an ageing population and a rising burden of non-communicable diseases that raise the cost of the promise as the window narrows.

A deadline is a useful discipline, and I would rather India aim at universal cover and fall a little short than never set the mark at all. Yet a deadline is not a plan. The ambition still has to withstand the realities of affordability, public trust, and a health budget that has yet to reach the level it requires. When 2047 arrives, this vision will not be judged by the number of cards issued or the platforms launched, but by whether the protection gap narrowed and OOPE kept falling. That is the version of 2047 I hoped for when I first imagined it, and on the current evidence, it remains ours to win or to lose.


Comments

Popular posts from this blog

State of Women’s Health in India

The fifth National Family Health Survey 2019-21 (NFHS-5) conducted by the Ministry of Health and Family Welfare, Government of India, provides extensive insights on population, health and nutrition at the country and state/union territory level and even the estimates at the district level. The survey touches on over 130 parameters across 21 sub-categories, with some specific to women and children and others aimed at a broader population. It also provides a comparison of the performance of the urban and rural population. For the first time, the sex ratio of the total population (females per 1,000 males) crossed the four-figure mark. It stood at 1,020 females per 1,000 males vis-à-vis 991 in NFHS-4 conducted in 2015-16. This is a significant achievement and success of the government measures against the practice of female infanticide. A major contribution towards this achievement is the enactment of Pre-Natal Diagnostic Technique (PNDT) Act, 1994, which prohibits sex selection and the mi...

Mind the Gap

The Constitution of India states that it is the “ duty of the State to raise the level of nutrition and standard of living and to improve public health ” (Government of India, 1950) . However, for the past decade, the public health expenditure in India continues to hover around one per cent of the gross domestic product (GDP) (MoHFW, 2019) . According to the World Bank, India is a Lower Middle-Income country, but its spending on healthcare is even less than the countries in the Lower Income Group. Since government financing is a function of the taxes that it raises, countries with a higher tax to GDP ratio tends to have better-financed healthcare systems. Low and middle-income countries with not so robust tax to GDP ratio finds it difficult to meet the demand for financing the healthcare of its citizens completely. With a tax to GDP ratio falling to a decade low of 9.88 per cent in FY20 (Seth, 2020) , naturally, public financing in India is insufficient to meet the healthcare require...

PMJAY Revisited: The Cost of Treatment That Inflation Forgot

Replying to a question in the Rajya Sabha on 28 July 2026, the Minister of State for Health and Family Welfare, Prataprao Jadhav, informed Parliament that over 447.3 million Ayushman cards have now been generated under the Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (PMJAY), and that as of 30 June 2026, the scheme had authorised 126.9 million hospital admissions worth INR 1,920 billion. A post on this blog in December 2020 ( PMJAY: Average cost per treatment is 2.5 per cent of the sum assured ) ran a simple back-of-the-envelope calculation. At that time, the scheme had recorded about 14 million admissions worth INR 175 billion, averaging INR 12,500 per admitted patient. The question raised then was whether a scheme whose average claim was this modest really needed a headline cover of up to INR 500,000 per family per year. Five and a half years on, the same arithmetic is worth repeating. The average cost of treatment has increased from INR 12,500 to INR 15,130. On the face of it,...